Related Experiment Video
Updated: Dec 10, 2025

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement
Published on: December 11, 2017
Long-term Outcomes of Endovascular Repair for Blunt Thoracic Aortic Injury: A 10 Year Multi-center Experience
Mingwei Wu1, Zhaoxiang Zeng2, Xianhao Bao2
1Department of Vascular and Endovascular Surgery, Chinese People's Liberation Army General Hospital, Beijing, China.
Insights
Thoracic endovascular aortic repair (TEVAR) is safe and effective for blunt thoracic aortic injuries (BTAI), showing excellent long-term outcomes. Extended follow-up is recommended for younger patients to monitor potential endograft-aorta mismatch over time.
Area of Science:
- Vascular Surgery
- Trauma Surgery
- Cardiovascular Imaging
Background:
- Blunt thoracic aortic injuries (BTAI) are severe trauma with high mortality.
- Thoracic endovascular aortic repair (TEVAR) has emerged as a less invasive alternative to open repair.
- Long-term outcomes of TEVAR for BTAI require further investigation.
Purpose of the Study:
- To assess the long-term safety and effectiveness of TEVAR in patients with BTAI.
- To evaluate clinical outcomes and complications following TEVAR for BTAI.
Main Methods:
- Retrospective observational study at 3 centers from January 2010 to December 2019.
- Included 62 consecutive patients with BTAI treated with TEVAR.
- Follow-up included CT angiography at 6 months and annually thereafter, with a mean follow-up of 86.82 months.
Main Results:
- 100% technical success rate across dissection, pseudoaneurysm, and rupture types.
- Low in-hospital (1.61%) and all-cause follow-up mortality (3.28%).
- Minimal long-term complications: 4.92% branch stenosis/occlusion, with 3.28% requiring re-intervention; no spinal cord ischemia, endoleak, or migration.
Conclusions:
- TEVAR demonstrates long-term safety and effectiveness for BTAI.
- Extended follow-up is crucial for young BTAI patients to monitor potential endograft-aorta interactions.
- This study provides robust evidence supporting TEVAR as a durable treatment option for BTAI.
Objective:
This study aimed to assess the long-term outcomes in patients treated by thoracic endovascular aortic repair (TEVAR) for blunt thoracic aortic injuries (BTAI).
Materials And Methods:
From January 2010 to December 2019, this retrospective observational study was conducted at 3 centers, involving 62 consecutive BTAI patients who underwent TEVAR. Computed tomography angiography scans were planned to be conducted at 6 months post-procedure, and annually thereafter.
Results:
Technical success was achieved in all 62 procedures (100%), which included cases of dissection (n=35, 56.45%), pseudoaneurysm (n=20, 32.26%), and rupture (n=7, 11.29%). Mean injury severity score was 31.66±8.30. A total of 21 supra-arch branches were revascularized by chimney technique, with 12 cases involving the left subclavian artery (LSA) and 9 cases involving the left common carotid artery. In addition, 11 LSAs were covered during the procedure. The in-hospital mortality rate was 1.61% (n=1). The mean follow-up time was 86.82±30.58 months. The all-cause follow-up mortality rate was 3.28% (n=2). Stenosis or occlusion of 3 supra-arch branches (4.92%) was identified at follow-up, with 2 cases (3.28%) requiring re-intervention. No spinal cord ischemia, endoleak, or migration was observed.
Conclusions:
Despite only including patients with long-term follow-up, this study confirms the long-term safety and effectiveness of TEVAR for BTAI. For young BTAI patients, as the thoracic aorta increases with age, longer follow-up is needed to observe the potential mismatch between the endograft and the aorta.Clinical ImpactThis study confirms the long-term safety and effectiveness of endovascular treatment for blunt thoracic aortic injury (BTAI). For young BTAI patients, as the thoracic aorta increases with age, longer follow-up is needed to observe the potential mismatch between the endograft and the aorta. Through a remarkably extended follow-up period (86.82±30.58 months) conducted at multiple centers in China, this study confirms the long-term safety and effectiveness of endovascular treatment for BTAI.
Related Concept Videos
Aneurysm III: Interprofessional Care
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Flail Chest-II
Assessment:
1. Clinical Evaluation:
History:

